Cargando…
Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.
Blood pharmacokinetics and tissue distribution of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a boron carrier with postulated melanin-seeking properties for boron neutron capture therapy, were determined in C57/BL mice with subcutaneous pigmented or non-pigmented B16 melanomas. Borocaptate sodium...
Autores principales: | Verrijk, R., Smolders, I. J., Huiskamp, R., Gavin, P. R., Philipp, K. H., Begg, A. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968811/ https://www.ncbi.nlm.nih.gov/pubmed/8142252 |
Ejemplares similares
-
Rational Coformer Selection in the Development of 6-Propyl-2-thiouracil Pharmaceutical Cocrystals
por: Acebedo-Martínez, Francisco Javier, et al.
Publicado: (2023) -
Bis[3-(dihydroxyboryl)anilinium] sulfate
por: Vega, Araceli, et al.
Publicado: (2010) -
tert-Butyl 2-(dihydroxyboryl)pyrrole-1-carboxylate
por: Klis, Tomasz, et al.
Publicado: (2008) -
Theranostics in Boron Neutron Capture Therapy
por: Sauerwein, Wolfgang A. G., et al.
Publicado: (2021) -
Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy
por: Morris, G M, et al.
Publicado: (2000)